May 28, 2024
Multi-cancer early detection (MCED) tests represent a breakthrough in medical science for their ability to identify multiple cancers with a single blood draw, thus improving mortality and morbidity outcomes.
In this article, RGA’s team of experts- Andrew Gaskell, Dr. Heather Lund, Raman Lalia- explore what this could mean for insurers and the challenges of modeling and quantifying MCED tests’ potential impact. Read more
Further News
October, 2024
Call for Speakers: Participate in the EAA e-Conference on ‚Data Science & Data Ethics‘
October, 2024
All recordings from the 4e Colloque International de l’Actuariat Francophone now available
October, 2024
Webinar on the new ASTIN Master Class
October, 2024
TOP10 most-viewed videos on Climate Risk
September, 2024
Searching for Simplicity: Improving customer comprehension in life insurance through behavioral science
September, 2024
Speaker of the Month September: Tatiana Bitunska
September, 2024
New AAE paper on Explainable AI for C-Level Executives